Tag: alirocumab

Posted onApril 13, 2020July 24, 2020Cardiovascular Disease

Clinical Trials of PCSK9 Inhibitors

by admin

proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates plasma LDL-C levels by regulating the LDL receptors on cell membrane. These proteins bind to LDL receptors and…

Subscribe via Email

Name*

Email*

Select list(s)*

Cardiovascular Disease

Infectious Disease

Dermatology

Emergency Medicine

Endocrinology

Gastroenterology

Geriatrics

Hematology/Oncology

Nephrology

Neurology

Surgery

Pulmonary/Critical Care

Rheumatology

Please accept terms & condition

Amphibious Theme by TemplatePocket ⋅ Powered by WordPress